Guest commentary

GPs need to show they can handle their end-of-life funds when raising a new fund.

Negotiations and arrangements for the remaining portfolio – including potential secondaries sales – can prove fiendishly complicated, writes Julia Corelli of law firm Pepper Hamilton.

In the third part of our series, Cyril Demaria, head of private markets at Wellershoff & Partners, argues the wait for returns is not as long as people think.

In the second part of our series, Cyril Demaria, head of private markets at Wellershoff & Partners, examines the evidence that secondaries perform better than funds of funds.

In the first of a three-part series, Cyril Demaria, head of private markets at Wellershoff & Partners, says that new entrants into the secondaries market often underestimate the amount of information and level of insight required to succeed.

The strategy is an increasingly popular way of refreshing global private equity exposure in the region, and buyers need to be savvy about the terrain, writes Atlantic-Pacific Capital’s Charles Wan.

Credit Suisse’s Jonathan Abecassis responds to our assessment of GP-led fund restructurings and the need for a genuine ‘do-nothing’ option for LPs.

Intermediary PEFOX's Kishore Kansal explains how the wall of capital may have turned into the market's most significant limiting factor, hindering its full potential.

In this second part of our Q&A, advisor Evercore's Nigel Dawn discusses GP-led deals and where that sector of the market might go from here.

In this second part of our Q&A with law firm Proskauer, Mike Suppappola and Kate Simpson discuss the use of special purpose vehicles in structured secondaries and treading a fine line in fund restructurings and recapitalisations.